Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Starts in 3 weeks from now
LocationRoyal Library of Belgium (KBR)
The conference “Research Infrastructures in a Changing Global, Environmental and Socio-economical Context” organised in the frame of the Belgian Presidency of the European Council will focus on 3 main issues:
RIs are increasingly faced with a changing global context, facing a volatile and unstable geopolitical situation on the global scene, new and rapidly changing political priorities (open strategic autonomy, digital and environmental transition, mission-oriented policies…). This requires flexibility, capacity to adapt and resilience. RI’s are already confronted with the scarcity of some crucial raw material and disruption in the supply chain. The conference will explore the value of RIs to open strategic autonomy, their contributions to key political objectives like the Green Deal and look at the broad ecosystem, the relation with national/regional RIs and other initiatives and instruments.
We offer news and event updates, covering all domains and topics of Horizon 2020 & Horizon Europe.
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.